B Wolach, L Choc, A Pomeranz, Y Ben Ari, D Douer, A Metzker
{"title":"Aplastic anemia in neonatal lupus erythematosus.","authors":"B Wolach, L Choc, A Pomeranz, Y Ben Ari, D Douer, A Metzker","doi":"10.1001/archpedi.1993.02160330031012","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To describe an infant with neonatal lupus erythematosus associated with aplastic anemia.</p><p><strong>Setting: </strong>The pediatric department in a tertiary-care hospital.</p><p><strong>Interventions: </strong>Packed red blood cell transfusions and a 3-week course of high-dose steroid therapy.</p><p><strong>Measurements/main results: </strong>The patient presented with severe anemia and a circumscribed, reticular, macular rash on the face and neck at 5 months of age. Skin lesion biopsy revealed epidermic hyperkeratosis, hydropic degeneration of the basal layer, and deposition of immunoglobulins and granular C1q at the dermoepidermal junction. Ro/SS-A antibodies were present in the infant. BFU-E (erythroid progenitor burst-forming unit) colonies in bone marrow increased by about tenfold when suppressor CD8+ T lymphocytes were removed, indicating immune suppression of hematopoiesis. High-dose steroid therapy failed. The infant subsequently developed gram-negative sepsis, severe metabolic acidosis, and consumptive coagulopathy and died.</p><p><strong>Conclusions: </strong>Neonatal lupus erythematosus may present as part of a spectrum. The disease may range from mild and transient to a severe, life-threatening condition requiring immediate intervention, as in the case reported here. This is the first report of neonatal lupus associated with aplastic anemia due to immune-mediated suppression of hematopoiesis.</p>","PeriodicalId":75474,"journal":{"name":"American journal of diseases of children (1960)","volume":"147 9","pages":"941-4"},"PeriodicalIF":0.0000,"publicationDate":"1993-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archpedi.1993.02160330031012","citationCount":"36","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of diseases of children (1960)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1001/archpedi.1993.02160330031012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 36
Abstract
Objective: To describe an infant with neonatal lupus erythematosus associated with aplastic anemia.
Setting: The pediatric department in a tertiary-care hospital.
Interventions: Packed red blood cell transfusions and a 3-week course of high-dose steroid therapy.
Measurements/main results: The patient presented with severe anemia and a circumscribed, reticular, macular rash on the face and neck at 5 months of age. Skin lesion biopsy revealed epidermic hyperkeratosis, hydropic degeneration of the basal layer, and deposition of immunoglobulins and granular C1q at the dermoepidermal junction. Ro/SS-A antibodies were present in the infant. BFU-E (erythroid progenitor burst-forming unit) colonies in bone marrow increased by about tenfold when suppressor CD8+ T lymphocytes were removed, indicating immune suppression of hematopoiesis. High-dose steroid therapy failed. The infant subsequently developed gram-negative sepsis, severe metabolic acidosis, and consumptive coagulopathy and died.
Conclusions: Neonatal lupus erythematosus may present as part of a spectrum. The disease may range from mild and transient to a severe, life-threatening condition requiring immediate intervention, as in the case reported here. This is the first report of neonatal lupus associated with aplastic anemia due to immune-mediated suppression of hematopoiesis.